Abstract
Intrathecal agmatine (decarboxylated arginine) moderates induction of neuropathic pain, spinal cord injury, and opioid tolerance in rodents. An endogenous central nervous system molecule and N-methyl-D-aspartate receptor antagonist/nitric oxide synthase inhibitor, agmatine may be a neuromodulator. We evaluated depolarization-induced release of agmatine from purified spinal nerve terminals (synaptosomes). Agmatine immunoreactivity was observed colocalized or closely apposed to some synaptophysin-and/or synaptotagmin-labeled structures. A temperature- and concentration-dependent uptake of [3H]-agmatine into synaptosomes was observed, consistent with an uptake mechanism. Potassium-induced depolarization resulted in release of [3H]- agmatine from the synaptosomes in a Ca2+-dependent manner, consistent with a neuromodulatory function. These results agree with previous reports of agmatine uptake into synaptosomes of the brain and extend those results to include stimulated release and a spinal site of activity.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 13-17 |
| Number of pages | 5 |
| Journal | Neuroreport |
| Volume | 17 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 2006 |
Keywords
- Arginine
- Neuromodulator
- Neurotransmitter
- Polyamine
- Spinal cord
Fingerprint
Dive into the research topics of 'Release of tritiated agmatine from spinal synaptosomes'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS